Omnitrope 30iu (10mg)
Omnitrope 30iu (10mg) is a Sandoz somatropin injection supplied as a 10mg/1.5mL cartridge for use with the compatible Omnitrope Pen 10. Each pack contains 1 ready-to-use cartridge for subcutaneous administration. The product should be stored refrigerated at 2°C to 8°C and used only as prescribed by a qualified healthcare professional.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Omnitrope 30iu (10mg)
Omnitrope 30iu (10mg) is a prescription somatropin product manufactured by Sandoz. The cartridge contains recombinant human growth hormone in a ready-to-use liquid formulation designed for subcutaneous administration with the compatible Omnitrope Pen 10 delivery system. This presentation is intended for patients who have been prescribed somatropin by a qualified healthcare professional and require the 10 mg/1.5 mL cartridge strength.
Product Details
Brand: Omnitrope
Active substance: Somatropin (recombinant human growth hormone)
Strength: 10 mg/1.5 mL, commonly expressed as approximately 30 IU
Dosage form: Solution for injection
Pack size: 1 cartridge
Route of administration: Subcutaneous use
Manufacturer: Sandoz
Compatible device: Omnitrope Pen 10
Prescription status: Prescription medicine
What Is Omnitrope 30iu (10mg)?
Omnitrope contains somatropin, a laboratory-produced form of human growth hormone. Somatropin has the same primary amino-acid sequence as naturally occurring human growth hormone and acts on growth-hormone receptors in the body. It is supplied as a clear, colorless sterile solution in a prefilled cartridge, so no reconstitution is required for this 10 mg/1.5 mL presentation.
The cartridge is intended for use with the corresponding Omnitrope Pen 10. The pen is a separate delivery device and should be used only according to the manufacturer’s instructions and the training provided by a doctor, pharmacist, or other qualified healthcare professional.
Approved Medical Use
Omnitrope is prescribed for specific growth-related conditions in children and for confirmed growth hormone deficiency in adults. The exact indication depends on the patient’s diagnosis, age, clinical history, and local prescribing information. Treatment should be started and monitored by a healthcare professional experienced in growth hormone therapy.
This product should not be used simply for bodybuilding, athletic performance, or general anti-aging purposes. The dose and duration of treatment are individualized and should not be changed without medical supervision.
Cartridge and Administration Information
The 10 mg/1.5 mL cartridge is designed for multiple injections by a single patient when used with the Omnitrope Pen 10. A new sterile disposable pen needle should be used for each injection. Injection sites are normally rotated to reduce the risk of local tissue changes.
Do not share an Omnitrope pen, cartridge, or needle with another person, even if the needle has been replaced. Sharing injection equipment can transmit infection. Patients or caregivers should receive proper instruction before using the cartridge at home.
Storage
Keep unopened Omnitrope cartridges refrigerated at 2°C to 8°C. Do not freeze. Store the cartridge in its original packaging to protect it from light.
After first use, the cartridge should remain in the compatible pen and continue to be stored in a refrigerator at 2°C to 8°C. Official product information allows the 10 mg/1.5 mL cartridge to be kept for up to 28 days after first use. Do not use the solution if it has been frozen, if the cartridge is damaged, or if the liquid is not clear and colorless.
Important Safety Information
Somatropin is not appropriate for every patient. It may be contraindicated in people with certain acute critical illnesses, active malignancy, some severe complications associated with Prader-Willi syndrome, or particular eye conditions related to diabetes. A healthcare professional should review the patient’s full medical history before treatment.
Possible adverse effects can include fluid retention, joint or muscle discomfort, headache, injection-site reactions, changes in blood glucose, and other effects that may require monitoring. New or persistent symptoms should be discussed with the prescribing clinician.
Why This Presentation May Be Prescribed
The Omnitrope 10 mg/1.5 mL cartridge provides a ready-to-use somatropin solution for patients already prescribed this strength. Its cartridge format avoids mixing powder and diluent and works with the dedicated Omnitrope Pen 10 for controlled delivery.
Always confirm the prescribed strength, cartridge condition, expiry date, storage history, and compatible pen before use. Omnitrope 30iu (10mg) should be supplied and used only under a valid prescription and appropriate medical supervision.






